Highlights and Quick Summary
- Total current liabilities for the quarter ending March 31, 2023 was $46.7 Million (a -40.58% decrease compared to previous quarter)
- Year-over-year quarterly Total current liabilities increased by 56.29%
- Annual Total current liabilities for 2022 was $78.6 Million (a 127.0% increase from previous year)
- Annual Total current liabilities for 2021 was $34.6 Million (a -17.76% decrease from previous year)
- Annual Total current liabilities for 2020 was $42.1 Million (a -65.73% decrease from previous year)
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Total current liabilities of Precigen, Inc.
Most recent Total current liabilitiesof PGEN including historical data for past 10 years.Interactive Chart of Total current liabilities of Precigen, Inc.
Precigen, Inc. Total current liabilities for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $46.73 | – | – | – | – |
| 2022 | $78.65 | $104.86 | $29.9 | $25.6 | $78.65 |
| 2021 | $34.65 | $28.99 | $28.87 | $25.24 | $34.65 |
| 2020 | $42.13 | $30.66 | $64.1 | $70.64 | $42.13 |
| 2019 | $122.91 | $81.96 | $51.63 | $59.42 | $122.91 |
| 2018 | $61.56 | $92.33 | $83.25 | $76.58 | $61.56 |
| 2017 | $80.17 | $87.8 | $95.69 | $90.65 | $80.17 |
| 2016 | $94.61 | $100.52 | $95.5 | $77.94 | $94.61 |
| 2015 | $75.9 | $77.09 | $122.81 | $48.7 | $75.9 |
| 2014 | $47.48 | $39.26 | $20.69 | $22.21 | $47.48 |
| 2013 | – | $19.83 | $19.72 | $17.51 | $19.83 |
| 2012 | – | – | – | – | $16.72 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology